Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDairy Crest Regulatory News (DCG)

  • There is currently no data for DCG

Interim Management Statement

11 Feb 2016 07:00

RNS Number : 7070O
Dairy Crest Group PLC
11 February 2016
 

 

11 February 2016

 

Dairy Crest Group plc ("Dairy Crest")

 

Interim Management Statement

 

Dairy Crest is today issuing its Interim Management Statement for the nine months ended 31 December 2015.

 

Trading Performance

 

The outlook for the full year remains in line with our expectations.

 

In a challenging market, our cheese and spreads brands have performed well, with all four key brands increasing or maintaining value share in the quarter. Combined sales of Cathedral City, Country Life, Clover and Frylight over the nine month period have remained broadly in line with the same period last year and volumes have increased by 2%. This is a robust performance in what remains a deflationary environment for both cheese and spreads.

 

In the third quarter, Cathedral City and Frylight have built on the strong performances seen in the first half of the year. Clover Simple, which has no artificial ingredients, launched successfully in September 2015 and Clover volumes have since grown year on year. Country Life sales volumes have increased markedly in the third quarter, benefitting from promotional activity built around the "Best of British" packaging.

 

Production of Infant Formula Ingredients begins

 

Production of demineralised whey powder and galacto-oligosaccharide ("GOS") has commenced at our factory in Davidstow. These are both ingredients for the growing, global infant formula market which will give Dairy Crest access to new growth markets and customers.

 

On 18 December 2015, Dairy Crest announced that it had acquired the outstanding 50% share of Promovita Ingredients Limited ('Promovita'), the joint venture established to develop and produce GOS. This gives Dairy Crest sole control over the development of the GOS business and trials looking into further applications for GOS are continuing.

 

Dairy Crest Innovation Centre

 

In December 2015, our innovation team moved into a new state of the art Innovation Centre on the Harper Adams University campus. This unique collaboration gives us access to leading food and agricultural research and will enhance our innovation capability in the future.

 

Sale of Dairies operations

 

On 26 December 2015 Dairy Crest successfully completed the Sale of its Dairies operations to Müller UK & Ireland Group ("Müller"). This is a transformative moment for Dairy Crest and the wider dairy sector. The UK dairy industry suffered a very difficult 2015. Milk production was high and realisations remained very low. In this environment, losses in our Dairies division continued until the sale on 26 December 2015.

 

Final proceeds are subject to certain adjustments and these are yet to be finalised. We now expect net proceeds before working capital adjustments to be around the lower end of our £40-£50 million guidance. Furthermore, we anticipate a negative working capital adjustment resulting in net proceeds before costs to be approximately £30 million.

 

Debt

 

Underlying cash generation in the retained business remains strong. However, higher than anticipated pre-sale losses in Dairies, the resultant impact on the sale proceeds and the £6 million acquisition of Promovita shares will impact reported levels of net debt at the year end.

 

 

New joint corporate brokers

 

We are pleased to announce the appointment of Peel Hunt and Shore Capital as the Company's two joint brokers with immediate effect. JP Morgan Cazenove will continue to act as financial adviser to the Company.

 

 

Mark Allen, Chief Executive of Dairy Crest, commented:

 

"Dairy Crest is now a branded and added-value business well placed to achieve profitable and sustainable growth.

 

"The strength of our brands is demonstrated by their performance in a challenging, deflationary consumer environment.

 

"We are also entering an exciting new chapter for Dairy Crest. Our functional ingredients business will be a key part of Dairy Crest in the future, giving us access to new growth markets.

 

"The outlook for the full year remains in line with our expectations."

 

 

Dairy Crest will issue its Preliminary Results for the year ending 31 March 2016 on 19 May 2016.

 

 

 

For further information, please contact:

Dairy Crest

Olivia Seccombe

01372 472249

Dairy Crest

Tom Atherton

01372 472264

Brunswick

Mike Smith

0207 404 5959

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSQBLFFQLFLBBK
Date   Source Headline
31st Jan 201811:43 amRNSTotal Voting Rights & Capital
31st Jan 20187:00 amRNSTrading Update
26th Jan 20182:51 pmRNSDirector/PDMR Shareholding
18th Jan 20183:53 pmRNSDirector and PCA Dealing
17th Jan 20187:00 amRNSExecutive Director Notification
9th Jan 201810:28 amRNSDirector / PDMR Shareholding
3rd Jan 20183:39 pmRNSDirector/PDMR Shareholding
2nd Jan 20189:38 amRNSTotal Voting Rights & Capital
5th Dec 20179:29 amRNSTR-1
30th Nov 201710:43 amRNSTotal Voting Rights & Capital
28th Nov 20177:00 amRNSNon-Executive Director Appointment
22nd Nov 20172:17 pmRNSStandard form for notification of major holdings
20th Nov 201710:40 amRNSDirector/PDMR Shareholding
13th Nov 201710:28 amRNSStandard form for notification of major holdings
9th Nov 20177:00 amRNSInterim Results
3rd Nov 20171:56 pmRNSTotal Voting Rights
2nd Oct 20177:00 amRNSTotal Voting Rights
21st Sep 201712:11 pmRNSTR-1: form for notification of major holdings
18th Sep 20177:00 amRNSTrading Statement
8th Sep 20177:00 amRNSActuarial valuation agreed for the pension fund
4th Sep 20172:37 pmRNSDirector / PDMR Shareholding
31st Aug 20171:42 pmRNSTotal Voting Rights
17th Aug 20172:03 pmRNSDirector / PDMR Shareholding
15th Aug 201710:15 amRNSDirector/PDMR Shareholding
9th Aug 201710:12 amRNSBLOCK LISTING SIX MONTHLY REVIEW
31st Jul 201712:11 pmRNSTotal Voting Rights & Capital
18th Jul 20174:51 pmRNSResults of Annual General Meeting
18th Jul 20177:00 amRNSAGM and Interim Management Statement
7th Jul 20171:36 pmRNSDirector/PDMR Shareholding
30th Jun 20172:30 pmRNSTotal Voting Rights
30th Jun 201711:15 amRNSTotal Voting Rights
16th Jun 201710:43 amRNS2017 Annual Report & Accounts & Notice of AGM
2nd Jun 201710:36 amRNSTotal Voting Rights
26th May 20173:54 pmRNSDirector / PDMR Shareholding
19th May 201712:47 pmRNSBlock Listing Six Monthly Review
18th May 20177:00 amRNSPreliminary Results
28th Apr 201710:40 amRNSTotal Voting Rights
12th Apr 201712:02 pmRNSNotification of Major Interest in Shares
31st Mar 20179:21 amRNSTotal Voting Rights & Capital
2nd Mar 20173:16 pmRNSTotal Voting Rights
9th Feb 20177:00 amRNSInterim Management Statement
31st Jan 201711:29 amRNSTotal Voting Rights & Capital
27th Jan 201712:51 pmRNSDirector/PDMR Shareholding
10th Jan 20171:38 pmRNSDirector / PDMR Shareholding
10th Jan 20171:27 pmRNSDirector / PDMR Shareholding
10th Jan 20171:24 pmRNSDirector / PDMR Shareholding
3rd Jan 201710:59 amRNSTotal Voting Rights
21st Dec 20167:00 amRNSDairy Crest announces research partnership
30th Nov 201612:58 pmRNSTotal Voting Rights & Capital
24th Nov 20161:02 pmRNSBLOCK LISTING SIX MONTHLY REVIEW

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.